Related Experiment Videos
Cimetidine induced pancytopenia. Effect on human CFU-MIX colony formation
W Uyttenbroeck1, M Korthout, R De Bock
1Laboratory of Experimental Haematology, University of Antwerp, Belgium.
Abstract:
We describe a 26 year-old male with a pancytopenia possibly due to cimetidine. Using progenitor cell culture techniques we investigated the mechanism of this bone marrow toxicity. Our results show a cimetidine dose-dependent inhibition of normal human CFU-GM colony formation as described by Fitchen and Koeffler in 1980. No differences in growth inhibition were found between the patients' recovery marrow and the controls. Toxicity on normal human CFU-MIX colony formation was, however, far more pronounced. At concentrations as low as 5 micrograms/ml the numbers of CFU-MIX colonies were decreased by almost 20% and more than 30% in cultures of two normal bone marrow samples. A significant decrease in CFU-MIX colony size was measured even at therapeutic levels (0.5 micrograms/ml). No obvious decrease in CFU-GM colony size was noticed at low concentrations. Experiments with T-cell- and monocyte-depleted bone marrow samples gave similar results: a pronounced inhibition of the CFU-MIX colony formation at low concentrations of cimetidine whereas the CFU-GM formation was less affected. It is therefore very unlikely that Accessory cells play part in the cimetidine induced CFU-MIX inhibition. Our results suggest the existence of H2 histamine receptors on human CFU-MIX (= multipotent progenitor cell). Blocking these receptors prevents the multipotent progenitor cell from going into the DNA-synthesis phase of the cell cycle.
Insights
Cimetidine can cause pancytopenia by inhibiting human multipotent progenitor cells (CFU-MIX). This drug blocks H2 histamine receptors, preventing cell cycle progression and DNA synthesis, impacting blood cell production.
Area of Science:
- Hematology
- Pharmacology
- Cell Biology
Background:
- Pancytopenia is a potential side effect of cimetidine.
- The exact mechanism of cimetidine-induced bone marrow toxicity requires elucidation.
Observation:
- Cimetidine demonstrated a dose-dependent inhibition of normal human CFU-GM colony formation.
- CFU-MIX colony formation showed significantly greater toxicity compared to CFU-GM, even at therapeutic cimetidine concentrations.
- Inhibition of CFU-MIX was observed irrespective of accessory cells, suggesting a direct effect.
Findings:
- Cimetidine directly inhibits human CFU-MIX colony formation.
- A significant decrease in CFU-MIX colony size was noted at therapeutic cimetidine levels.
- The study suggests the presence of H2 histamine receptors on human CFU-MIX cells.
Implications:
- Cimetidine's toxicity may stem from blocking H2 histamine receptors on multipotent progenitor cells.
- This receptor blockade could impede the DNA synthesis phase of the cell cycle.
- Understanding this mechanism could inform strategies to mitigate cimetidine-related hematological adverse effects.